Abstract:The objective of this study was to report our experience of endovascular therapy for subclavian artery aneurysm (SAA) as well as its long-term outcomes. A total of 34 patients (19 men; mean age, 51 years) with SAA (27 true aneurysms, 5 pseudoaneurysms, and 2 chronic dissected aneurysms) underwent successful endovascular procedures in our center from 2008 to 2018. The demographics and procedural details were retrospectively reviewed. Postoperative complications and long-term outcomes were followed up with clinical evaluation, ultrasound, or computed tomography. Embolization of the aneurysm without stent was performed in one patient. A total of 50 stents were used for the remaining 33 patients, with one stent for 19 SAAs (57.6%), two stents for 10 SAAs (30.3%), and three stents for 4 SAAs (12.1%). Parallel stents, in which one was placed in the right subclavian artery (RSA) and the other in the right common carotid artery (RCCA), were used in four patients with right SAA. Identifying the RSA origin, measuring the landing zone, and releasing the stent were performed on the tangential position of RSA and RCCA to avoid accidental coverage of the RCCA. Completion angiography showed nine type I endoleaks (26.5%) and one type II endoleak (2.9%). Type I endoleaks were treated with balloon dilation and additional stents, and all type I endoleaks resolved after this management. Type II endoleak in one patient was left without reintervention, and follow-up computed tomography angiography showed that it disappeared at 6 months. Twenty-nine patients (85.3%) with an average follow-up time of 70.7 months (range, 6-123 months) are still alive with patent stents. Three patients (9.1%) had intimal hyperplasia at 12, 24, and 72 months after the procedure, respectively. One patient (3.0%) had in-stent restenosis at 30 months. One patient (3.0%) underwent reintervention 48 months postoperatively for a dissecting aneurysm at the distal end of the primary stent. No other severe complications were found during the follow-up. With careful evaluation of lesions and election of strategies, endovascular treatment is a safe and effective therapeutic option for repairing SAA. Long-term outcomes are encouraging, with a low rate of endoleak and a high rate of stent patency.

Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor*

Multiple predictors of in-stent restenosis after stent implantation in symptomatic intracranial atherosclerotic stenosis.

Predictors of Recurrent Angina in Patients with No Need for Secondary Revascularization.

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

The Long Term Results Of Vertebral Artery Ostium Stenting In A Single Center

ECG changes in prolonged treatment of kala-azar with antimony compounds.

Stenting for atheros clerotic subclavian artery stenosis/occlusion A retrospective case series analysis and follow-up results

Degeneracy, mimicry and crossreactivity in immune recognition.

Atrial double potential associated with electrical connection between the coronary sinus musculature and the left atrium in a patient with Wolff-Parkinson-White syndrome.

Endovascular Stenting for Atherosclerotic Subclavian Artery Stenosis in Patients with Other Craniocervical Artery Stenosis

Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction

Endovascular and Surgical Management of Subclavian Artery Occlusive Disease: Early and Long-Term Outcomes

690 Residual In-stent Carotid Stenosis and Cigarette Smoking are Predictors of Restenosis After Stenting (CAS)

MISC 6. Endovascular Therapy for Subclavian Artery Aneurysm and its Long-term Outcomes

Long-term effect of intervention therapy for atherosclerotic lesions of subclavian artery

Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up

Long-term outcomes of endovascular therapy for right subclavian artery occlusive lesions: A multi-center experience

Epithelial and Mesenchymal Cell Biology Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway

Predictive Factors for In-stent Restenosis after Balloon-mounted Stent Placement for Symptomatic Intracranial Atherosclerosis

Clinical study of 57 cases of endovascular treatment for total subclavian artery occlusion

Interventional treatment of stenotic or occlusive subclavian artery